Tubular medical device
11554033 · 2023-01-17
Assignee
Inventors
Cpc classification
A61F2/958
HUMAN NECESSITIES
A61F2/064
HUMAN NECESSITIES
A61F2002/30579
HUMAN NECESSITIES
A61F2250/0048
HUMAN NECESSITIES
A61F2/966
HUMAN NECESSITIES
A61F2/89
HUMAN NECESSITIES
A61F2/954
HUMAN NECESSITIES
International classification
A61F2/95
HUMAN NECESSITIES
A61F2/24
HUMAN NECESSITIES
A61F2/954
HUMAN NECESSITIES
A61F2/958
HUMAN NECESSITIES
Abstract
Apparatus for progressively dilating the lumen of a narrow natural vessel such as an iliac artery and implanting a tubular device enabling access through the dilated lumen to conduct subsequent procedures via the dilated lumen, includes an inflatable integrated balloon locatable at least partially within the tubular device, the tubular device having a length L1 providing a self-expanding tubular body having at least a portion including stents, so that when the integrated balloon is removed the dilated lumen of the natural vessel remains dilated and supported by the tubular device.
Claims
1. A tubular medical system, comprising: a) a self-expanding tubular body (31, 243) having a bifurcated configuration that includes, i) a stented tubular length portion (L.sup.1) that includes self-expanding stents, ii) a pair of bifurcated limbs, including a. a crimped tubular length portion (L.sup.2), the crimped tubular length portion (L.sup.2) being secured to the stented tubular length portion (L.sup.1), b. an access branch (34) at the crimped tubular length portion (L.sup.2); b) a removable sheath (230, 241) radially constricting the stented tubular length portion (L.sup.1); and c) a delivery system that includes, i) an operator handle (220), including a splitter mechanism (224), through which the removable sheath (230, 241) extends, ii) a delivery shaft (249) extending from the operator handle (220), and at least partially within the stented tubular length portion (L.sup.1), iii) a pull handle (232) at the operator handle (220), iv) straps (233) extending from the pull handle (232) to the removable sheath (230, 241), whereby the removable sheath (230, 241) is split by pulling on the pull handle (232), v) an integrated balloon (15, 245) within the self-expanding tubular body (31, 243), whereby inflation of the integrated balloon (15, 245) after removal of the removable sheath (230, 241) enables further radial expansion of the stented tubular length portion (L.sup.1) of the self-expanding tubular body (31, 243).
2. The tubular medical system of claim 1, wherein the integrated balloon (15, 245) is undersized in relation to a maximum potential expanded dimension of the tubular body (31, 243).
3. The tubular medical system of claim 1, further including an internal valve at the access branch (34).
4. The tubular medical system of claim 3, wherein the valve includes an introducer seal.
5. The tubular medical system of claim 1, wherein the access branch (34) has an outer surface and further includes a plurality of tabs or ribbon loops (38) attached to the outer surface.
6. The tubular medical system of claim 1, wherein the stented tubular length portion (L.sup.1) is expandable and includes saddle-shaped ring stents (244), each of which has peak (252) and valley portions (253).
7. The tubular medical system of claim 1, wherein the stented tubular length portion (L.sup.1) includes a lining of a polytetrafluoroethylene (PTFE).
8. The tubular medical system of claim 1, wherein the operator handle (220) of the delivery system further includes a hub (222).
9. The tubular medical system of claim 8, wherein the operator handle (220) of the delivery system further includes a grip (223).
10. The tubular medical system of claim 1, wherein the operator handle (220) of the delivery system further includes a grip (223).
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) In the following description additional detail of embodiments will be described by way of illustrative example with reference to the accompanying drawings.
(2) The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate embodiments of the invention and together with the detailed description herein, serve to explain the principles of the invention. The drawings are only for purposes of illustrating preferred embodiments and are not to be construed as limiting the invention. It is emphasized that, in accordance with the standard practice in the industry, various features are not drawn to scale. In fact, the dimensions of the various features may be arbitrarily increased or reduced for clarity of discussion. The foregoing and other objects, features and advantages of the invention are apparent from the following detailed description taken in conjunction with the accompanying drawings in which:
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
DETAILED DESCRIPTION FOR CARRYING OUT THE INVENTION
(27) In the embodiment illustrated in
(28) The implantable graft is made of fabric in the form of a collapsible sleeve, at least part of which 13 may be crimped or pleated. The tubular length portion L.sup.1 and the further tubular length portion L.sup.2 respectively may be made of the same or different fluid-impermeable fabrics selected from physiologically acceptable or benign materials such as a knitted or woven fabric of ePTFE, PTFE or polyester, polyethylene or polypropylene. The fabric may be sealed with a sealant, for example gelatine or collagen.
(29) The stents 11 are separate deformable ring stents which are individually attached to the fabric sleeve. At least some of these stents 11, optionally all, may be made from a shape-memory metallic or plastics material so as to be self-expanding. Each of the ring stents 11 may be made of continuous loop of resilient material such as stainless steel, or a shape memory metal alloy like nitinol (a nickel-titanium alloy) or high modulus polymers such as polyether ether ketone PEEK or the like, and may be attached to the endovascular section 10 by way of sutures, adhesive or heat bonding as appropriate. Each ring stent 11 may be formed from a shape memory material which may be heat set against the external surface of the endovascular section 10. In the depicted example, the undulating contour of each ring stent 11 comprises a compressible memory material readily forming two peaks 20 and two valleys 22 to form in use a “ ” saddle-shaped” ring stent. Use of a continuous loop of multiple windings of nitinol wire is advantageous for this purpose
(30) A suitable delivery system for the implantable graft disclosed herein includes an integrated balloon dilator for inter alia assisting expansion of the unsheathed endovascular section 10, and at least initiating dilation of the natural vessel. An example of a balloon 15, has a collapsible tubular shape with tapering ends. The tubular shape has truncated cone-shaped tapered sections 16, 17 respectively on the distal and proximal ends of a straight tubular profile section 18, which tapered sections 16, 17 are fixed to a tubular element 19 to define therebetween an expansion volume which may at its fullest extent of expansion exceed the initial natural volume of the corresponding length of the narrow lumen target natural vessel.
(31) The narrow lumen target natural vessel may be a part of the vasculature that is naturally narrow and tortuous such as the iliac arteries, or any natural vessel lumen constricted by stenosis, stricture or calcification.
(32) In use of this embodiment, the implantable graft overlies the integrated balloon 15 sufficiently to be expandable during inflation to provide support to a lumen of a natural vessel dilated at least partially by the integrated balloon, and packaged for delivery within a removable sheath, particularly such that the endovascular section 10 would be compactly sheathed for delivery into a target narrow natural vessel of the vasculature and unsheathed using a release strap or wire attached to the sheath when at least the endovascular section 10 is located in position within the target natural vessel. After removal of the sheath, the balloon 15 would be inflated within the expanding or partially expanded endovascular section 10 so as to dilate the natural vessel to at least a first extent.
(33) Where additional dilation is required, for example to admit an EVAR system, the delivery system and integrated balloon dilator would be withdrawn and another balloon of greater dilation capacity would be delivered on a suitable further delivery system, inflated to further dilate the natural vessel and permit additional expansion of the endovascular section 10 and then that further delivery system and balloon would be removed after deflation of the balloon. The procedure can be repeated by substitution of further balloons until the natural vessel is fully dilated, or event ruptured whilst the fully expanded endovascular section serves as an implantable graft lumen of a desired lumen patency.
(34) In an embodiment illustrated in
(35) One of the bifurcated limbs serves as a perfusion branch 36 which may be anastomosed to a natural vessel 60 (
(36) The other of the bifurcated limbs serves as an access branch 34 for introduction or removal of a delivery system component, and for conducting an EVAR procedure.
(37) At least a portion of the access branch 34 has a trimmable length comprising a series of sections 37, each section having a tab or loop 38 which may be gripped to facilitate trimming of the length of that branch limb of the tubular body 31.
(38) The implantable graft is made of fabric in the form of a collapsible sleeve. The tubular length portion L.sup.1 and the further tubular length portion L.sup.2 respectively may be made of the same or different fluid-impermeable fabrics selected from physiologically acceptable or benign materials such as a knitted or woven fabric of ePTFE, PTFE or polyester, polyethylene or polypropylene. The fabric may be sealed with a sealant, for example gelatine or collagen.
(39) The endovascular section 30 includes stents 41 which are separate ring stents which are individually attached to the fabric sleeve and configured for final use to support a dilated fabric sleeve as “saddle” shaped stents having peak 42 and valley 43 portions.
(40) Each of the ring stents 41 may be made of continuous loop of resilient material such as stainless steel, or a shape memory metal alloy like nitinol (a nickel-titanium alloy) or high modulus polymers such as polyether ether ketone PEEK or the like, and may be attached to the fabric sleeve by way of sutures, adhesive or heat bonding as appropriate.
(41) Each ring stent 41 may be formed from a shape memory material which may be heat set against the external surface of the endovascular section 30. In the depicted example (
(42) Thus the stented endovascular section is self-expanding and can assume a fully open lumen dimension after the target natural vessel is fully dilated by means of the balloon.
(43) In use, referring to
(44) After preparing the surgical field in accordance with current recommended medical practice, the target natural vessel, for example the iliac, is located by reference to the inguinal ligament, which runs from the anterior superior iliac spine to the pubic tubercle.
(45) Then an appropriate incision is made and retracted to expose the target iliac, which is tied off (by ligature) and an incision is made into the iliac, to provide an access point for insertion of a bifurcated endovascular tubular device including a branch suitable for use for perfusion.
(46) A guidewire is introduced (Seldinger wire technique) into the iliac to prepare for introduction of a delivery system with endovascular tubular device. An endo-section of the latter being threaded and guided into the iliac over the guidewire.
(47) Suitable haemostat clamps are applied to the device including to a perfusion branch of a tubular device carried by the delivery system, and the advancing of the delivery system into the iliac via the incision access point is initiated sufficiently to present the perfusion branch to the iliac at a point remote from the first insertion incision point.
(48) The perfusion branch is then anastomosed to the iliac to complete a perfusion by-pass pathway through the endovascular tubular device.
(49) At this stage in the procedure it is possible to vent air from the delivery system via an internal valve 62 associated with a tubular part of the tubular device, and a stented endo-portion of the tubular device is deployed within the natural vessel that is at least partially dilated by means of an integrated balloon carried by the delivery system upon which the tubular device is positioned.
(50) The expansion of the deployed tubular device proceeds along with inflation of the integrated balloon from an external fluid supply device (e.g. syringe indicated
(51) The delivery system with integrated balloon is withdrawn through a valve located within a tubular part of the tubular device, leaving the inflated stented endo-portion of the tubular device supporting a dilated portion of the iliac.
(52) Where the dilated portion of the iliac needs to be further dilated, for example, to permit transit of an EVAR system, a larger balloon on another delivery system can be inserted through the valve located within the tubular device and subsequently inflated to further expand the previously inflated stented endo-portion of the tubular device, whereafter the second balloon can deflated and withdrawn on its delivery system leaving the stented endo-portion of the tubular device in a further expanded state to enlarge the already dilated iliac to a greater lumen dimension. The use of further balloons of ever-increasing inflation capacity in repeated steps such as above described may be implemented until the natural vessel is sufficiently dilated or ruptured to allow the endovascular stented tubular body portion L.sup.1 to be adequately expanded to permit access for an EVAR system. The tubular device remains implanted as a resident tubular graft substituting for the possibly ruptured iliac vessel and having sufficient lumen dimensions for access to the vasculature beyond the tubular graft implant site in the iliac.
(53) Assuming the iliac has been sufficiently dilated by the successive use of the balloons, the resident expanded tubular device maintains sufficient patency for an EVAR system to be threaded onto the guidewire (Seldinger guidewire technique) for subsequent introduction through the tubular device and onward through the vasculature to a site requiring deployment of an endograft.
(54) The delivery system can be removed and the surgical procedure concluded in accordance with normal good practice.
(55) Referring to
(56)
(57)
(58) The tubular device 240 provides an implantable graft similar to the tubular devices 31, 231 as described above. The tubular device 240 comprises two tubular sections secured together for example by sutures 242 to form a blood-tight seal and forming a hollow tubular body 243 having a length dimension L comprising a tubular length portion L1 and a further tubular length portion L2. The tubular length portion L1 forms an endovascular section 250 and has a plurality of stents 244 which are compressible to a compact form and expandable to support the tubular length L1 in an expanded (dilated) configuration. The compact form can be held for delivery by use of a removable sheath, as depicted. The implantable graft includes the integrated balloon 245 which may expand the endovascular section 250 when the section 250 is unsheathed. The balloon 245, has a collapsible tubular shape with tapering ends. The tubular shape has truncated cone-shaped tapered sections 246, 247 respectively on the distal and proximal ends of a straight tubular profile section 248, which tapered sections 246, 247 are fixed to a tubular element 249 to define therebetween an expansion volume which may exceed the natural volume of the corresponding length of the target natural vessel. The endovascular section 250 includes the stents 244 which are separate ring stents which are individually attached to the fabric sleeve and configured for final use to support a dilated fabric sleeve as “saddle” shaped stents having peak 252 and valley 253 portions.
(59) The delivery system is of the type described with reference to
(60) The use of the embodiment of
(61) The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has”, and “having”), “include” (and any form of include, such as “includes” and “including”), and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a method or device that “comprises,” “has,” “includes,” or “contains” one or more steps or elements possesses those one or more steps or elements, but is not limited to possessing only those one or more steps or elements. Likewise, a step of a method or an element of a device that “comprises,” “has,” “includes,” or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features. Furthermore, a device or structure that is configured in a certain way is configured in at least that way, but may also be configured in ways that are not listed.
(62) The invention has been described with reference to the preferred embodiments. It will be understood that the architectural and operational embodiments described herein are exemplary of a plurality of possible arrangements to provide the same general features, characteristics, and general system operation. Modifications and alterations will occur to others upon a reading and understanding of the preceding detailed description. It is intended that the invention be construed as including all such modifications and alterations.